載入...
Dendritic cell-based vaccines: barriers and opportunities
Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option. However, DC-based vaccines face sever...
Na minha lista:
| 發表在: | Future Oncol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4260651/ https://ncbi.nlm.nih.gov/pubmed/23130928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.12.125 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|